(EMAILWIRE.COM, July 29, 2009 ) Las Vegas NV - These medical stocks showed up on our alert tracking system in early trading on Wednesday morning:

Elron Electronic Industries Ltd. (NASDAQ & TASE: ELRN) announced yesterday Medingo Ltd., a group company held 92% by Elron and its subsidiary, RDC - Rafael Development Corporation Ltd., has received formal clearance from the Food and Drug Administration ("FDA"), to market its Solo(TM) MicroPump Insulin Delivery System in the United States. Up around 65.7% in early morning trading.

ViroPharma Incorporated (NASDAQ: VPHM) reported today its financial results for the second quarter ended June 30, 2009. Up approx. 15.2% in early trading.

Evotec AG (NASDAQ: EVTC) today announced that a further research milestone, leading to payments to Evotec, has been successfully achieved in its drug discovery collaboration with Boehringer Ingelheim. The milestone was achieved for the identification and selection of a second compound to be advanced into preclinical development within an existing program. Up about 13.5% in early trading.

Join us on twitter at www.twitter.com/premarketdata
Contact: info@PreMarketData.com
www.PreMarketData.com


Join PreMarketData.com’s large community of Wall St. professionals to receive news, views and alerts. It’s always free to our subscribers at www.PreMarketData.com

About - PreMarketData.com publishes The Week Ahead report. This informational purposes only report provides a look back at the previous weeks market action and a collection of information including dates and times of market moving data coming in the week ahead compiled from industry sources. PreMarketData.com from time to time publishes Op-Ed and informational pieces on its web site and will send out breaking market news alerts to it’s subscribers as it happens.

Disclaimer

PreMarketData.com is a wholly owned subsidiary of Investors Direct Inc. The material contained in this is release is intended to be strictly informational. This article may contain forward looking statements. The accuracy and completeness of the information supplied is not warranted and is derived from a variety of sources and third parties which may or may not be reliable. Investors Direct Inc. and PreMarketData.com disclaim any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may also contain technical inaccuracies or typographical errors. This material is being provided for informational purposes only. PreMarketData.com is NOT a registered investment advisor or a broker dealer. This information neither is, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by Investors Direct Inc., or PreMarketData.com. PreMarketData.com does not offer or provide any investment advice or opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make. Such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.
PreMarketData.com or its officers and directors may hold positions in the companies mentioned in this report. PreMarketData.com may also receive compensation from companies mentioned in this report so please read our compensation disclosure which can be found at www.PreMarketData.com.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PreMarketData.com undertakes no obligation to update such statements.
Always do your own due diligence.
Visit our web site, www.PreMarketData.com for further risks and disclosures.

Contact Information:
Premarketdata.com
Media Contact
Tel: 702 544 2396
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.